Live from the NIH registry
Studies recruiting near Buffalo right now
Top 25 of 524 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Roswell Park Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: SWOG Cancer Research Network
Inhaled Isopropyl Alcohol for Treatment of Nausea
Vomiting, Nausea
Phase 2, Phase 3
Interventional 84 participants sought
Oishei Children's Hospital — Buffalo, New York (1.8 mi)
· Sponsor: State University of New York at Buffalo
Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
Pediatric Cancer
N/A
Observational 35 participants sought
Roswell Park Comprehensive Cancer Center — Buffalo, New York (1.8 mi)
· Sponsor: H. Lee Moffitt Cancer Center and Research Institute
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Amherst, New York (5.8 mi)
· Sponsor: TG Therapeutics, Inc.
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
Dent Neurologic Institute — Amherst, New York (5.8 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer
Phase 3
Interventional 590 participants sought
Roswell Park Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: Revolution Medicines, Inc.
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Erie County Medical Center ( Site 0175) — Buffalo, New York (1.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University Telemedicine — Buffalo, New York (1.8 mi)
· Sponsor: Sameek Roychowdhury
ELEVATE High-Risk PCI Pivotal Study
High-Risk Percutaneous Coronary Intervention (High-risk PCI)
N/A
Interventional 290 participants sought
Buffalo General Medical Center — Buffalo, New York (1.8 mi)
· Sponsor: Magenta Medical Ltd.
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Solid Tumor, Non-Small-Cell Lung Cancer
Phase 1
Interventional 364 participants sought
Roswell Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: Astellas Pharma Inc
Neuromodulation and Neuroimaging in Older Children With Mild Traumatic Brain Injury
Brain Concussion, Mild Traumatic Brain Injury
N/A
Interventional 10 participants sought
Ghazala Saleem — Buffalo, New York (1.8 mi)
· Sponsor: State University of New York at Buffalo
A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer
Carcinoma, Non-small-Cell Lung
Phase 1
Interventional 126 participants sought
Roswell Park Comprehensive Cancer Center — Buffalo, New York (1.8 mi)
· Sponsor: Johnson & Johnson Enterprise Innovation Inc.
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Oncology, MEK Mutation
Phase 1
Interventional 230 participants sought
Roswell Park — Buffalo, New York (1.8 mi)
· Sponsor: Nested Therapeutics, Inc
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Leukemia, Leukemia, Myeloid
Phase 1
Interventional 170 participants sought
Roswell Park Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: BlossomHill Therapeutics
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
Generalized Myasthenia Gravis
Phase 3
Interventional 180 participants sought
Dent Neurological Institute — Buffalo, New York (1.8 mi)
· Sponsor: Novartis Pharmaceuticals
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Sisters of Charity Hospital — Buffalo, New York (1.8 mi)
· Sponsor: Duke University
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
PARKINSON DISEASE (Disorder)
Phase 2
Interventional 80 participants sought
Vima Site #055 — Amherst, New York (5.8 mi)
· Sponsor: Vima Therapeutics
The Pediatric Anesthesia Quality Improvement Project
Surgery, Anesthesia
N/A
Observational 5,000,000 participants sought
Womens and Childrens Hospital of Buffalo — Buffalo, New York (1.8 mi)
· Sponsor: The Society for Pediatric Anesthesia
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
Aortic Valve Insufficiency, Aortic Valve Stenosis
N/A
Interventional 200 participants sought
University of Buffalo — Buffalo, New York (1.8 mi)
· Sponsor: Edwards Lifesciences
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Roswell Park Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: Children's Oncology Group
A Study of ASP3082 in Adults With Advanced Solid Tumors
Solid Tumor
Phase 1
Interventional 681 participants sought
Roswell Park Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: Astellas Pharma Inc
MMA Embolization for Refractory Chronic Migraine
Migraine Disorders
N/A
Interventional 70 participants sought
University of Buffalo Medical Center — Buffalo, New York (1.8 mi)
· Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)
Aneurysm
N/A
Interventional 10 participants sought
Jacobs Institute — Buffalo, New York (1.8 mi)
· Sponsor: Jacobs institute
Robotic Minimally Invasive Inguinal Hernia Repair Post-Market Clinical Study With the DEXTER Robotic System
Inguinal Hernia Repair
N/A
Observational 140 participants sought
Northtowns Ambulatory Surgical Center (NASC) — Buffalo, New York (1.8 mi)
· Sponsor: Distalmotion SA
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Large B-cell Lymphoma, Lymphoma, B-Cell
Phase 3
Interventional 400 participants sought
Roswell Park Comprehensive Cancer Center — Buffalo, New York (1.8 mi)
· Sponsor: Lyell Immunopharma, Inc.